Monitoring the plasma concentration of ripretinib and its metabolites in Chinese patients with gastrointestinal stromal tumors in a real‐life setting
Ripretinib and its metabolites maintained consistent plasma concentrations in Chinese patients with advanced GIST. Furthermore, a trough ripretinib concentration >475 ng/mL was associated with extended survival.
Authors
- Ye Zhou (ORCID: https://orcid.org/0000-0002-8780-0099)
- Hao Xu (ORCID: https://orcid.org/0000-0001-9685-7364)
- Zekuan Xu (ORCID: https://orcid.org/0000-0001-5179-4128)
- Qiang Zhang (ORCID: https://orcid.org/0000-0002-5857-327X)
- Rui Wang (ORCID: https://orcid.org/0000-0003-1723-4746)
- Ming Wang (ORCID: https://orcid.org/0000-0003-1071-4472)
- Yongqing Wang (ORCID: https://orcid.org/0000-0001-8340-6003)
- Fengyuan Li (ORCID: https://orcid.org/0000-0003-1821-3357)
- Xin Wu (ORCID: https://orcid.org/0000-0002-3839-4768)
- Yongjian Zhou (ORCID: https://orcid.org/0000-0002-4036-4592)
- Xiaofeng Sun
- Haoran Qian
- Linsen Zhou
- Luning Sun (ORCID: https://orcid.org/0000-0001-5715-1035)
Institutions
- Fujian Medical University (CN)
- Shanghai Medical College of Fudan University (CN)
- Shanghai Jiao Tong University (CN)
- Nantong University (CN)
- Renji Hospital (CN)
- Sir Run Run Shaw Hospital (CN)
- Chinese PLA General Hospital (CN)
- Fudan University Shanghai Cancer Center (CN)
- Nanjing Drum Tower Hospital (CN)
- Ministry of Education (KR)
- Yancheng First People's Hospital (CN)
- Yancheng Third People's Hospital (CN)
- Jiangsu Cancer Hospital (CN)
- Yancheng Second People's Hospital (CN)
- Jiangsu Province Hospital (CN)
- Union Hospital (CN)
- Zhejiang University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Cancer
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/cncr.70149
- Primary Topic
- Gastrointestinal Tumor Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Government of Jiangsu Province
- Natural Science Foundation of Jiangsu Province
- Nanjing Medical University
- Chinese Society of Clinical Oncology
- Priority Academic Program Development of Jiangsu Higher Education Institutions